Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liana J. Hsu"'
Autor:
Erin C, Cobry, Lauren G, Kanapka, Eda, Cengiz, Lori, Carria, Laya, Ekhlaspour, Bruce A, Buckingham, Korey K, Hood, Liana J, Hsu, Laurel H, Messer, Melissa J, Schoelwer, Emma, Emory, Katrina J, Ruedy, Roy W, Beck, Raj Paul, Wadwa, Linda, Gonder-Frederick, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic variability. Person-reported outcomes (PROs) are essential to assess the utility of new devices and their impact on quality of life. This article focuses on the
Autor:
Bruce A. Buckingham, Justin Wang, Liana J Hsu, Laya Ekhlaspour, Rie von Eyben, Rayhan A. Lal, Marina Basina
Publikováno v:
Diabetes Technology & Therapeutics. 23:1-7
Background: This study assessed the efficacy and safety of ultrarapid insulin Fiasp® in the hybrid closed-loop MiniMed™ 670G system. Methods: This was a pilot randomized double-blinded crossover st...
Autor:
Christian A. Wakeman, Liana J Hsu, Sue A. Brown, Bruce A. Buckingham, Trang T. Ly, Jessica Robic, Stacey M. Anderson, Mary C. Oliveri, Lisa M. Norlander, Charlotte L. Barnett, Sarah E. Loebner, Boris Kovatchev, Marc D. Breton, Ryan S. Kingman, Paula Clinton, Suzette Reuschel-DiVirglio
Publikováno v:
Diabetes Technol Ther
Background: Typically, closed-loop control (CLC) studies excluded patients with significant hypoglycemia. We evaluated the effectiveness of hybrid CLC (HCLC) versus sensor-augmented pump (SAP) in reducing hypoglycemia in this high-risk population. Me
Autor:
Melissa J, Schoelwer, Lauren G, Kanapka, R Paul, Wadwa, Marc D, Breton, Katrina J, Ruedy, Laya, Ekhlaspour, Gregory P, Forlenza, Erin C, Cobry, Laurel H, Messer, Eda, Cengiz, Emily, Jost, Lori, Carria, Emma, Emory, Liana J, Hsu, Stuart A, Weinzimer, Bruce A, Buckingham, Rayhan A, Lal, Mary Clancy, Oliveri, Craig C, Kollman, Betsy B, Dokken, Daniel R, Cherñavvsky, Roy W, Beck, Mark D, DeBoer, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in user
Autor:
the iDCL Trial Research Group, Roy W. Beck, Daniel Cherñavvsky, Betsy B. Dokken, Craig Kollman, Mary Oliveri, Bruce A. Buckingham, Mark D. DeBoer, Stuart A. Weinzimer, Liana J. Hsu, Emma Emory, Lori Carria, Emily Jost, Melissa J. Schoelwer, Eda Cengiz, Gregory P. Forlenza, Laya Ekhlaspour, Katrina J. Ruedy, Marc D. Breton, R. Paul Wadwa, Lauren G. Kanapka
Objective: To further evaluate the safety and efficacy of the Control-IQ closed loop control (CLC) system in children with type 1 diabetes. Research Design and Methods: Following a 16-week randomized clinical trial (RCT) comparing CLC with sensor aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5edbd08406fd9aaa7a8035cc8b6acc
https://doi.org/10.2337/figshare.13260212.v1
https://doi.org/10.2337/figshare.13260212.v1
Autor:
Gregory P. Forlenza, Liana J Hsu, Emily Boranian, Cari Berget, Bruce A. Buckingham, R. Paul Wadwa, Mark D. DeBoer, Marc D. Breton, Emma Emory, Laya Ekhlaspour, Lisa M. Norlander, Melissa J Schoelwer, Ryan S. Kingman
Publikováno v:
Diabetes Technology & Therapeutics
Background: Glycemic control is particularly challenging for toddlers and preschoolers with type 1 diabetes (T1D), and data on the use of closed-loop systems in this age range are limited. Materials and Methods: We studied use of a modified investiga